ГоловнаArchive of numbers2023Volume 31, issue 4(117)The content of glucose in the cerebrospinal fluid in patients with delirium tremens with cognitive impairments of varying severity
Title of the article The content of glucose in the cerebrospinal fluid in patients with delirium tremens with cognitive impairments of varying severity
Authors Linskiy Igor
Zadorozhnyi Volodymyr
Yurchenko Mykola
In the section DIAGNOSTICS AND THERAPY OF MENTAL AND NARCOLOGICAL DISORDERS
Year 2023 Issue Volume 31, issue 4(117) Pages 65-71
Type of article Scientific article Index UDK 616.853-008.441.13-06 Index BBK -
Abstract DOI: https://doi.org/10.36927/2079-0325-V31-is4-2023-9

 The purpose of the work is to determine the glucose content in the cerebrospinal fluid (CSF) and assess the state of the blood-brain barrier (BBB) in patients with delirium tremens (DT) with cognitive impairments (CI) of varying severity. 182 men in the acute period of DT were treated. The age of the patients ranged from 22 to 70 years. All patients had manifestations of CI. Two observation groups were formed from patients with DT: with moderately pronounced CI (104 people) and with significantly pronounced CI (78 people). Both groups included patients with manifestations of “classic” DT (diagnosis code according to ICD-10 F10.4) and with signs of various variants of severe DT (F10.43). The DRS R-98 — Delirium Rating Scale — Revised-98 were used to characterize the clinical manifestations of white fever. The duration of the period of mental disorders was additionally assessed. CSF was obtained by lumbar puncture. The concentration of glucose in blood and CSF was determined by the glucose oxidase method. A temporary increase in the level of glucose in the blood is typical for patients with DT, so 7.8 mmol/l was chosen as the upper limit of blood glucose in the study. The state of the BBB was assessed by the simultaneous use of two indicators, namely, the proportion of creatinine content in the CSF relative to its content in the blood, as well as the proportion of urea content in the CSF relative to its content in the blood. The obtained data were processed by the methods of mathematical statistics using Excel 2016 spreadsheets. It was established that in patients with DT, an increase in the expressiveness of CI is accompanied by a relative increase in the concentration of glucose in the CSF, which does not go beyond the reference values. The condition of the BBB is assessed as satisfactory. An increase in the concentration of glucose in the CSF in patients with DT correlates with an increase in the characteristic biorhythmic variability of CI. The existence of a previously unknown small cohort of patients with DT with the most pronounced CI, in which the level of glucose in the CSF exceeds that in the blood, has been registered.
Key words delirium tremens, cognitive impairments, glucose content in cerebrospinal fluid
Access to full text version of the article pdf download
Bibliography 1. American Psychiatric Association (2000). Diagnostic and Statistical Manual of Mental Disorders Fourth Edition Text Revision (DSM-IV-TR). Washington DC: American Psychiatric Association. https://doi.org/10.1176/appi.books.9780890423349.
2. Adrianova E. D., Damulin I.V., Sivolap Yu.P. Kognitivnyye rasstroystva pri alkogolizme [Cognitive dysfunctions during alcoholism]. Narkologiya [Narkology]. 2013. Vol. 12(6). P. 79—85. (In Russian). 3. Gofman A. G., Kozhinova T. A., Orlova M. A. Alkogolnyye psikhozy i ikh klassifikatsiya v MKB-10. Sotsialnaya i klinicheskaya psikhiatriya [Social and clinical psychiatry]. 2014. Vol. 24(3). P. 25—30. https://psychiatr.ru/files/magazines/2014_09_scp_775. pdf. (In Russian).
4. Bernardin F, Maheut-Bosser A, Paille F. Cognitive impairments in alcohol-dependent subjects. Front Psychiatry. 2014 Jul 16;5:78. doi: 10.3389/fpsyt.2014.00078. PMID: 25076914; PMCID: PMC4099962.
5. Hirsch JA, Nicola G, McGinty G, Liu RW, Barr RM, Chittle MD, Manchikanti L. ICD-10: History and Context. AJNR Am J Neuroradiol. 2016 Apr;37(4):596-9. doi: 10.3174/ajnr.A4696. Epub 2016 Jan 28. PMID: 26822730; PMCID: PMC7960170.
6. Tsvetanova E. M. Likvorologiya / per. s bolgarskogo. Kiyev : Zdorov’ya, 1986. 273 с. (In Russian). 7. Nigrovic LE, Kimia AA, Shah SS, Neuman MI. Relationship between cerebrospinal fluid glucose and serum glucose. N Engl J Med. 2012 Feb 9;366(6):576-8. doi: 10.1056/NEJMc1111080. PMID: 22316468.
8. Mosconi L, Pupi A, De Leon MJ. Brain glucose hypometabolism and oxidative stress in preclinical Alzheimer's disease. Ann N Y Acad Sci. 2008 Dec;1147:180-95. doi: 10.1196/ annals.1427.007. PMID: 19076441; PMCID: PMC2661241.
9. Trzepacz PT, Baker RW, Greenhouse J. A symptom rating scale for delirium. Psychiatry Res. 1988 Jan;23(1):89-97. doi: 10.1016/0165-1781(88)90037-6. PMID: 3363018.
10. Trzepacz PT, Mittal D, Torres R, Kanary K, Norton J, Jimerson N. Validation of the Delirium Rating Scale-revised-98: comparison with the delirium rating scale and the cognitive test for delirium. J Neuropsychiatry Clin Neurosci. 2001 Spring;13(2):229-42. doi: 10.1176/jnp.13.2.229. Erratum in:J Neuropsychiatry Clin Neurosci 2001 Summer;13(3):433. PMID: 11449030.
11. Zadorozhnyy V. V. Shkala otsenki dlitelnosti alkogolnogo deliriya. Materialy XVIII Ukrainskoi nauk.-prakt. konf. "Dovzhenkivski chytannia". Kharkiv : Pleiada, 2018. S. 51—52. (In Russian).
12. Leggio L, Ray LA, Kenna GA, Swift RM. Blood glucose level, alcohol heavy drinking, and alcohol craving during treatment for alcohol dependence: results from the Combined Pharmacotherapies and Behavioral Interventions for Alcohol Dependence (COMBINE) Study. Alcohol Clin Exp Res. 2009 Sep;33(9):1539-44. doi: 10.1111/j.1530-0277.2009.00982.x. Epub 2009 May 26. PMID: 19485973; PMCID: PMC2955866.
13. Pach D, Radomska M, Groszek B, Hydzik P, Gilis-Januszewska A, Pach J. Abnormal glucose metabolism in men with alcohol withdrawal syndrome. Przegl Lek. 2014;71(9):469-74. PMID: 25632784.
14. Deisenhammer F, Bartos A, Egg R, Gilhus NE, Giovannoni G, Rauer S, Sellebjerg F; EFNS Task Force. Guidelines on routine cerebrospinal fluid analysis. Report from an EFNS task force. Eur J Neurol. 2006 Sep;13(9):913-22. doi: 10.1111/j.1468- 1331.2006.01493.x. PMID: 16930354.
15. Malakhov V. O., Potapov O. O., Lychko V. S. Osnovy klinichnoi likvorolohii : navchalnyi posibnyk. Sumy : Sumskyi derzhavnyi universytet, 2016. S. 9, 11-18. https://essuir.sumdu. edu.ua/bitstream-download/123456789/44968/1/navch_Lychko. pdf;jsessionid=2628AB90BB3B8E1850FB76E55F2AF359. (In Ukrainian).
16. Dolgov V. V., Menshikov V. V. Klinicheskaya laboratornaya diagnostika: natsionalnoye rukovodstvo [Clinical laboratory diagnostics: national guidelines]. V 2 tomakh. Tom 1. M. : GEOTARMedia, 2012. 808 s. (Seriya "Natsionalnyye rukovodstva"). (In Russian).
17. Paraklinichni metody doslidzhennia v psykhiatrii : metodychni vkazivky dlia pidhotovky likariv-interniv do praktychnykh zaniat [Paraclinical methods of investigation in psychiatry: methodical instructions for training interns to take practical positions] / uporiad. H. M. Kozhyna, L. M. Haichuk, K. O. Zelenska. Kharkiv : KhNMU, 2018. 20 s. (In Ukrainian).
18. Mistur, Rachel & Mosconi, Lisa & De Santi, Susan & Guzman, Marla & Li, Yi & Tsui, Wai & de Leon, Mony. (2009). Current Challenges for the Early Detection of Alzheimer's Disease: Brain Imaging and CSF Studies. Journal of clinical neurology (Seoul, Korea). 5. 153-66. 10.3988/jcn.2009.5.4.153.
19. Dumurgier J, Paquet C, Peoc'h K, Lapalus P, Mouton- Liger F, Benisty S, Chasseigneaux S, Chabriat H, Hugon J. CSF Aβ₁–₄₂ levels and glucose metabolism in Alzheimer's disease. J Alzheimers Dis. 2011;27(4):845-51. doi: 10.3233/JAD-2011- 111007. PMID: 21897007.
20. Moyaert P, Padrela BE, Morgan CA, Petr J, Versijpt J, Barkhof F, Jurkiewicz MT, Shao X, Oyeniran O, Manson T, Wan DJJ, Günther M, Achten E, Mutsaerts HJMM, Anazodo UC. Imaging blood-brain barrier dysfunction: A state-of-the-art review from a clinical perspective. Front Aging Neurosci. 2023 Apr 17;15:1132077. doi: 10.3389/fnagi.2023.1132077. PMID: 37139088; PMCID: PMC10150073.
21. Jensen CS, Gleerup HS, Musaeus CS, Hasselbalch SG, Høgh P, Waldemar G, Simonsen AH. Cerebrospinal fluid glucose is not altered in patients with dementia. Clin Biochem. 2023 Feb;112:1-5. doi: 10.1016/j.clinbiochem.2022.12.005. Epub 2022 Dec 8. PMID: 36502885.
22. Huang J, van Zijl PCM, Han X, Dong CM, Cheng GWY, Tse KH, Knutsson L, Chen L, Lai JHC, Wu EX, Xu J, Chan KWY. Altered d-glucose in brain parenchyma and cerebrospinal fluid of early Alzheimer’s disease detected by dynamic glucose-enhanced MRI. Sci Adv. 2020 May 13;6(20):eaba3884. doi: 10.1126/ sciadv.aba3884. PMID: 32426510; PMCID: PMC7220384.
23. Mosconi L. Glucose metabolism in normal aging and Alzheimer’s disease: Methodological and physiological considerations for PET studies. Clin Transl Imaging. 2013 Aug;1(4):10.1007/ s40336-013-0026-y. doi: 10.1007/s40336-013-0026-y. PMID: 24409422; PMCID: PMC3881550.